Biography
Suzanne Nguyen provides strategic intellectual property advice particularly for early-stage life sciences companies and life sciences investors. Dr. Nguyen helps companies build and grow their patent portfolios and supports them during financing and transactions. Dr. Nguyen’s experience covers a wide array of technologies, including peptide or antibody-based therapeutics, radiopharmaceuticals, gene therapy, gene editing, epigenetics, immuno-oncology, cell therapies, and diagnostics.
Dr. Nguyen has been working in the field of intellectual property since 2007, beginning her career as a scientific advisor and then as a patent agent at another law firm. Dr. Nguyen also has previous in-house experience at a Swedish healthcare company.
- Molnlycke Health Care AB – Global Patent Advisor
- Advised biotech venture capital firm on IP due diligence matters in connection with new life sciences company formations
- Represented biotechnology company in intellectual property matters relating to antibody and antibody-drug conjugate therapeutics
- Represented non-profit research institute on intellectual property matters relating to stem cells, cell generation, and screening systems
- Assisted in IP due diligence on behalf of a biotech venture capital firm in connection with a Series A financing of a clinical-stage company developing antibody-drug conjugates to treat cancer
- Represented biotech company developing radioimmunoconjugates in intellectual property matters including during the company’s acquisition by a pharmaceutical company
- Represented a biotech company developing gene editing-based therapies in intellectual property matters and assisted on matters in connection with their Initial Public Offering
- Represented a biotech company in intellectual property matters related to peptide-based pharmaceuticals for ophthalmology indications
- Represented life sciences venture creation firm in intellectual property matters, including in connection with the formation of a company developing epigenomic controllers for therapeutic purposes
- Represented biotech company developing small molecule therapeutic for eye disorders in intellectual property matters including during the company’s acquisition by a pharmaceutical company
- Represented biotech company developing oncolytic viral therapies in intellectual property matters including in connection with investment by pharmaceutical company
- Assisted in successfully defending a pharmaceutical company’s enzyme replacement therapy patent in an Inter Partes Review proceeding
- Represented a venture-backed startup using synthetic biology and machine learning to develop therapies and vaccines in intellectual property matters
- “Innovating with AI in the life sciences,” presented at the Swedish American Chamber of Commerce, New England event “In the forefront of AI and Entrepreneurship,” Boston, MA, December 2024
- “Managing US Patent Prosecution from Abroad,” Global Patent Congress, Copenhagen, September 2014
- “Developments in US Patent Law,” Nordic Intellectual Property Rights Conference, Stockholm, March 2014
- Author, “What Young Inventors Need to Know about Patents,” Imagine Magazine (published by Johns Hopkins University Center for Talented Youth), February 2014
- Co-Author, “Ablation of de novo DNA methyltransferase Dnmt3a in the nervous system leads to neuromuscular defects and shortened lifespan,” Developmental Dynamics, June 2007
- Co-Author, “Suppression of Intestinal Neoplasia by Deletion of Dnmt3b,” Molecular and Cell Biology, 26(8): 2976-2983, April 2006
- Author, “Developmental Biology: A Field in Depth,” Imagine Magazine, December 2002
- Co-Author, “A Critical Role for Dnmt1 and DNA Methylation in T Cell Development, Function, and Survival,” Immunity, 157(5): 763-774, November 2001
- Co-Author, “Requirement of Shp-2 Tyrosine Phosphatase in Lymphoid and Hematopoietic Cell Development,” Blood, 97(4): 911-914, February 2001
- Co-Author, “Promoter Element for Transcription of Unrearranged T-Cell Receptor Beta-Chain Gene in Pro-T Cells,” Blood, 93(9): 3017-3025, May 1999
- Selected for inclusion in the Massachusetts Rising Stars list by Super Lawyers (2023-2026)
Suzanne Nguyen, Ph.D.
Partner
Credentials
Admissions
- Massachusetts
- U.S. Patent & Trademark Office (USPTO)
Education
Boston University School of Law, J.D. 2020
Massachusetts Institute of Technology, Ph.D 2007
California Institute of Technology, B.S. 1996
Prior Law Firm Experience
Goodwin Procter LLP
McDermott Will & Emery LLP
Choate Hall and Stewart LLP